Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron- capture therapy of cancer: Preparation by novel emulsion- droplet coalescence technique and characterization

Pharmaceutical Research

Volumn 16, Issue 12, 1999, Pages 1830-1835

  Tokumitsu, Hiroyuki ^a   Ichikawa, Hideki ^a   Fukumori, Yoshinobu ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Chitosan; Emulsion droplet coalescence; Gadolinium; Gadopentetic acid; Nanoparticle; Neutron capture therapy

Indexed keywords

CHITOSAN DERIVATIVE; GADOLINIUM PENTETATE; NANOPARTICLE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; DEVICE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RETENTION; EMULSION; MALE; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL;

EID: 0033404225     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018995124527     Document Type: Article

References (26)

1. Y. Kawashima, H. Yamamoto, H. Takeuchi, T. Hino, and T. Niwa. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur. J. Pharm. Biopharm. 45:41-48 (1998).
2. J. Vandorpe, E. Schacht, S. Dunn, A. Hawley, S. Stolnik, S.S. Davis, M. C. Garnett, M. C. Davies, and L. Illum. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer. Biomaterials 18:1147-1152 (1997).
3. J.-C. Leroux, E. Allémann, F. De Jaeghere, E. Doelker, and R. Gurny. Biodegradable nanoparticles - From sustained release formulations to improved site specific drug delivery. J. Contr. Rel. 39:339-350 (1996).
4. B. G. Müller, H. Leuenberger, and T. Kissel. Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharm. Res. 13:32-37 (1996).
5. T. Verrecchia, G. Spenlehauer, D. V. Bazile, A. Murry-Brelier, Y. Archimbaud, and M. Veillard. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanopanicles as injectable drug carriers. J. Contr. Rel. 36:49-61 (1995).
6. G. Skjask-Braek, T. Anthonsen, and P. Sandford. Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications, Elsevier Applied Science, London, 1989.
7. O. Felt, P. Buri, and R. Gurny. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24:979-993 (1998).
8. R. M. Brugger and J. A. Shih. Evaluation of gadolinium-157 as a neutron capture therapy agent. Strahlenther. Onkol. 165:153-156 (1989).
9. R. F. Barth and A. H. Soloway. Boron neutron capture therapy of primary and metastatic brain tumors. Mol. Chem. Neuropathol. 21:139-154 (1994).
10. 10B molecule-malanoma cell interaction from in vitro to first clinical trial. Pigment Cell Res. 2:226-234 (1989).
11. 157Gd. Nucl. Phys. A304:327-428 (1978).
12. 157Gd. Int. J. Radiat. Biol. 54:205-208 (1988).
13. V. F. Khokhlov, P. N. Yashkin, D. I. Silin, E. S. Djorova, and R. Lawaczeck. Neutron capture therapy with Gd-DTPA in tumor-bearing rats. In Y. Mishima (ed), Cancer Neutron Capture Therapy, Plenum Press, New York, 1996, pp. 865-869.
14. R. Lawaczeck, C.-O. Fischer, U. Krüger. W. Leuther, and J. Menrad. Gadolinium neutron capture therapy (GdNCT) with MRI contrast media. In vitro study. In Y. Mishima (ed), Cancer Neutron Capture Therapy, Plenum Press, New York, 1996, pp. 859-864.
15. Y. Akine, N. Tokita, K. Tokuuye, M. Satoh, H. Churei, C. L. Pechoux, T. Kobayashi, and K. Kanda. Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy. Jpn. J. Cancer Res. 84:841-843 (1993).
16. M. Takagaki, Y. Oda, S. Miyatake, H. Kikuchi, T. Kobayashi, K. Kanda, and Y. Ujeno. Killing effects of gadolinium neutron capture reactions on brain tumors. In B. J. Allen et al. (eds.), Progress in Neutron Capture Therapy for Cancer, Plenum Press, New York, 1992, pp. 407-410.
17. Y. Fukumori, H. Ichikawa, H. Tokumitsu, M. Miyamoto, K. Jono, R. Kanamori, Y. Akine, and N. Tokita. Design and preparation of ethyl cellulose microcapsules of gadopentetate dimeglumine for neutron-capture therapy using the Wurster process. Chem. Pharm. Bull. 41:1144-1148 (1993).
18. Y. Akine, N. Tokita, K. Tokuuye, M. Satoh, Y. Fukumori, H. Tokumitsu, R. Kanamori, T. Kobayashi, and K. Kanda. Neutron-capture therapy of murine ascites tumor with gadolinium-containing microcapsules. J. Cancer Res. Clin. Oncol. 119:71-73 (1992).
19. H. Tokumitsu, H. Ichikawa, Y. Fukumori, and L. H. Block. Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique. Chem. Pharm. Bull. 47:838-842 (1999).
20. A. Matsumura, Y. Shibata, T. Yamamoto, K. Nakagawa, S. Yasuda, S. Nakajima, I. Sakata, T. Yoshizawa, and T. Nose. Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): tumor enhancement agent for magnetic resonance imaging. Neurol. Med. Chir. (Tokyo) 37:327-331 (1997).
21. Y. M. Wang, H. Sato, I. Adachi, and I. Horikoshi. Optimization of the formulation design of chitosan microspheres containing cisplatin. J. Pharm. Sci. 85:1204-1210 (1996).
22. S. R. Jameela, A. Misra, and A. Jayakrishnan. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J. Biomater. Sci. Polymer Edn. 6:621-632 (1994).
23. A. Polk, B. Amsden, K. De Yao, T. Peng, and M. F. A. Goosen. Controlled release of albumin from chitosan-alginate microcapsules. J. Pharm. Sci. 83:178-185 (1994).
24. A. Berthold, K. Cremer, and J. Kreuter. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Contr. Rel. 39;17-25 (1996).
25. P. Calvo, C. Remuǹan-López, J. L. Vila-Jato, and M. J. Alonso. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 14:1431-1436 (1997)
26. L. Y. Lim and L. S. C. Wan. Heat treatment of chitosan films. Drug Dev. Ind. Pharm. 21:839-846 (1995).